FundingPayments

Correlia Biosystems: Raises $7M in Series A Funding

  • Correlia Biosystems, a Berkeley, CA-based life science startup, closed a $7m Series A financing round
  • The round led by Neotribe Ventures, joined by Cota Capital, the Regents of the University of California, and others
  • NeoTribe Ventures joins Correlia’s board of directors as part of the financing
  • The company also intends to use the funds for the commercial launch of its immunoassay platform
  • This will also the first instrument planned in their larger suite of proteomics tools focused on highly efficient and automated protein measurements
  • Correlia is launching a product to miniaturize Elisa, a quantitative test for proteins and antibodies widely used in drug development, vaccine development, and diagnostics
Previous article
Shinhan Bank: Enhanced Cooperations with partners in diversified fields
Next article
Alliance Data: Completes Acquisition of Bread
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

Nium Launches Dual-Network Stablecoin Card Issuance Platform

New platform aims to streamline stablecoin card issuance and enhance user experience.Highlights: Nium unveils a new platform for...
FinTech

Wise Launches UK Current Accounts, Expanding Financial Services

The new accounts aim to simplify banking for UK customers.Highlights: Wise introduces current accounts to UK market.The new...
FinTech

Lloyds Bank Strengthens Research on AI Impact in Software Engineering

The collaboration aims to explore the future of technology in banking.Highlights: Lloyds Bank partners with the University of...
FinTech

Valt Bank Secures De Novo Bank Charter, Expanding Banking Options

New bank charter enables Valt Bank to offer innovative financial services.Highlights: Valt Bank has been granted its de...